Associations between predicted vitamin D status, vitamin D intake, and risk of severe
25 (OH) Vitamin D Levels of Patients with COVID-19 are not Associated with
Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased
CRN Foundation’s Vitamin D & Me! Campaign
A single high-dose of 200,000 IU of vitamin D did not elicit meaningful changes in systemic inflammatory cytokines, chemokines, or growth factor among COVID-19 patients with already...
In this study, vitamin D deficiency did not correlate to COVID-19 infection rate. COVID-19 mortality was significantly associated with vitamin D deficiency.
The data from this study provides evidence that vitamin D may have an anti‐inflammatory effect on COVID‐19 patients and vitamin D may provide protective effects.
High prevalence of low vitamin D levels is associated with increased disease severity due to an increased immune-inflammatory response.
Though the results are not significant, Serum levels of 25(OH)D, vitamin B12, and especially zinc at the time of admission can affect clinical outcomes in COVID‐19 patients.
Low UV exposure can affect the required production of vitamin D in the body, which substantially influences the dynamics of COVID-19 transmission and severity.
